Tevogen Bio Holdings Inc.TVGNNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank75
3Y CAGR+168.9%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+168.9%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
19.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$18.52M-16.3%
2024$22.13M+444.9%
2023$4.06M+326.1%
2022$953083.00-42.7%
2021$1.66M-